ESC 365 - Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete reverse remodelling after aortic valve replacement

HFA Premium Access

Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete reverse remodelling after aortic valve replacement

Session: ePosters in basic science 2

Topic: Cardiac Diseases

Speaker: Doctor F. Trindade (Porto, PT)

Event: Heart Failure 2023

Congress Presentation

About the speaker

Doctor Fabio Trindade

Faculty of Medicine University of Porto, Porto (Portugal)

0 follower

2 more presentations in this session

Sexual dimorphism in heart failure: targeting the sex-specific fibrotic response

Speaker: Doctor L. Meems (Groningen, NL)

Biomechanical response of myosin modulator mavacamten in ultrathin slices of hypertrophic cardiomyopathy

Speaker: Doctor Y. Taverne (Rotterdam, NL)

Access the full session

ePosters in basic science 2

Speakers: Doctor F. Trindade, Doctor L. Meems, Doctor Y. Taverne

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by